181 related articles for article (PubMed ID: 3659096)
1. Genetic influences on tolerance development with chronic oxotremorine infusion.
Marks MJ; Romm E; Collins AC
Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of tolerance development after chronic oxotremorine treatment.
Marks MJ; Artman LD; Collins AC
Pharmacol Biochem Behav; 1983 Jul; 19(1):103-13. PubMed ID: 6622504
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
4. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
Collins AC; Smolen TN; Smolen A; Medhurst LJ
Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
[TBL] [Abstract][Full Text] [Related]
5. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration.
Lee W; Wolfe BB
Mol Pharmacol; 1989 Nov; 36(5):749-57. PubMed ID: 2555673
[TBL] [Abstract][Full Text] [Related]
6. Genetics of nicotine response in four inbred strains of mice.
Marks MJ; Burch JB; Collins AC
J Pharmacol Exp Ther; 1983 Jul; 226(1):291-302. PubMed ID: 6864548
[TBL] [Abstract][Full Text] [Related]
7. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
Marks MJ; Collins AC
Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
[TBL] [Abstract][Full Text] [Related]
8. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
Adem A; Sabbagh M; Nordberg A
J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
[TBL] [Abstract][Full Text] [Related]
9. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
11. A comparison of sensitivity to oxotremorine and muscarinic receptors in LS and SS mice.
Collins AC; Campbell SM; Romm E; Marks MJ
Alcohol Clin Exp Res; 1990 Aug; 14(4):605-15. PubMed ID: 2221290
[TBL] [Abstract][Full Text] [Related]
12. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
Costa LG; Schwab BW; Murphy SD
Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
[TBL] [Abstract][Full Text] [Related]
13. Chronic scopolamine treatment and brain cholinergic function.
Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
Smolen TN; Smolen A; Collins AC
Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
[TBL] [Abstract][Full Text] [Related]
15. Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility.
Aronstam RS; Kellogg C; Abood LG
Brain Res; 1979 Feb; 162(2):231-41. PubMed ID: 761088
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic adaptations to chronic oxotremorine infusion.
Marks MJ; Artman LD; Patinkin DM; Collins AC
J Pharmacol Exp Ther; 1981 Aug; 218(2):337-43. PubMed ID: 7252834
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
James MK; Cubeddu LX
J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
[TBL] [Abstract][Full Text] [Related]
18. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
Van de Kamp JL; Collins AC
Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
[TBL] [Abstract][Full Text] [Related]
19. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
Flynn DD; Mash DC
J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
[TBL] [Abstract][Full Text] [Related]
20. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
